Katherine E. Kelley

1.9k total citations · 1 hit paper
20 papers, 1.4k citations indexed

About

Katherine E. Kelley is a scholar working on Pediatrics, Perinatology and Child Health, Health, Toxicology and Mutagenesis and Obstetrics and Gynecology. According to data from OpenAlex, Katherine E. Kelley has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pediatrics, Perinatology and Child Health, 7 papers in Health, Toxicology and Mutagenesis and 5 papers in Obstetrics and Gynecology. Recurrent topics in Katherine E. Kelley's work include Effects and risks of endocrine disrupting chemicals (6 papers), Pregnancy and preeclampsia studies (5 papers) and Birth, Development, and Health (5 papers). Katherine E. Kelley is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (6 papers), Pregnancy and preeclampsia studies (5 papers) and Birth, Development, and Health (5 papers). Katherine E. Kelley collaborates with scholars based in United States and Taiwan. Katherine E. Kelley's co-authors include Allen A. Mitchell, Sonia Hernández–Dı́az, Martha M. Werler, Carol Louik, Suzanne M. Gilboa, Russ Hauser, Antonia M. Calafat, Mark A. Canfield, Jean D. Brender and Peter H. Langlois and has published in prestigious journals such as American Journal of Epidemiology, Environmental Health Perspectives and CHEST Journal.

In The Last Decade

Katherine E. Kelley

20 papers receiving 1.4k citations

Hit Papers

Medication use during pregnancy, with particular focus on... 2011 2026 2016 2021 2011 100 200 300 400 500

Peers

Katherine E. Kelley
Jennifer D. Peck United States
Katherine E. Kelley
Citations per year, relative to Katherine E. Kelley Katherine E. Kelley (= 1×) peers Jennifer D. Peck

Countries citing papers authored by Katherine E. Kelley

Since Specialization
Citations

This map shows the geographic impact of Katherine E. Kelley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine E. Kelley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine E. Kelley more than expected).

Fields of papers citing papers by Katherine E. Kelley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine E. Kelley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine E. Kelley. The network helps show where Katherine E. Kelley may publish in the future.

Co-authorship network of co-authors of Katherine E. Kelley

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine E. Kelley. A scholar is included among the top collaborators of Katherine E. Kelley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine E. Kelley. Katherine E. Kelley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Werler, Martha M., Stephen Kerr, Elizabeth C. Ailes, et al.. (2023). Patterns of Prescription Medication Use during the First Trimester of Pregnancy in the United States, 1997–2018. Clinical Pharmacology & Therapeutics. 114(4). 836–844. 16 indexed citations
2.
Dodge, Laura E., et al.. (2018). Medications as a potential source of exposure to parabens in the U.S. population. Environmental Research. 164. 580–584. 22 indexed citations
3.
Kelley, Katherine E., et al.. (2018). AN UNUSUAL CAUSE OF ENCEPHALOPATHY: STEROID RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS (SREAT). CHEST Journal. 154(4). 383A–384A. 1 indexed citations
4.
Vuong, Ann M., Mayura Shinde, Jean D. Brender, et al.. (2016). Prenatal Exposure to Nitrosatable Drugs, Dietary Intake of Nitrites, and Preterm Birth. American Journal of Epidemiology. 183(7). 634–642. 21 indexed citations
5.
Dodge, Laura E., Katherine E. Kelley, Paige L. Williams, et al.. (2015). Medications as a source of paraben exposure. Reproductive Toxicology. 52. 93–100. 64 indexed citations
6.
Vuong, Ann M., Mayura Shinde, Jean D. Brender, et al.. (2014). Nitrosatable Drug Exposure during Pregnancy and Preterm and Small‐for‐Gestational‐Age Births. Paediatric and Perinatal Epidemiology. 29(1). 60–71. 8 indexed citations
7.
Brender, Jean D., Peter J. Weyer, Paul A. Romitti, et al.. (2013). Prenatal Nitrate Intake from Drinking Water and Selected Birth Defects in Offspring of Participants in the National Birth Defects Prevention Study. Environmental Health Perspectives. 121(9). 1083–1089. 113 indexed citations
8.
Hernández–Dı́az, Sonia, et al.. (2013). Medications as a potential source of exposure to phthalates among women of childbearing age. Reproductive Toxicology. 37. 1–5. 60 indexed citations
9.
Shinde, Mayura, Ann M. Vuong, Jean D. Brender, et al.. (2013). Prenatal exposure to nitrosatable drugs, vitamin C, and risk of selected birth defects. Birth Defects Research Part A Clinical and Molecular Teratology. 97(8). 515–531. 6 indexed citations
10.
Brender, Jean D., Martha M. Werler, Mayura Shinde, et al.. (2012). Nitrosatable drug exposure during the first trimester of pregnancy and selected congenital malformations. Birth Defects Research Part A Clinical and Molecular Teratology. 94(9). 701–713. 26 indexed citations
11.
Kelley, Katherine E., et al.. (2012). “Phthalates”: Kelley et al. Respond. Environmental Health Perspectives. 120(11). 1 indexed citations
12.
Brender, Jean D., Martha M. Werler, Katherine E. Kelley, et al.. (2011). Nitrosatable Drug Exposure During Early Pregnancy and Neural Tube Defects in Offspring. American Journal of Epidemiology. 174(11). 1286–1295. 40 indexed citations
13.
Mitchell, Allen A., Suzanne M. Gilboa, Martha M. Werler, et al.. (2011). Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. American Journal of Obstetrics and Gynecology. 205(1). 51.e1–51.e8. 586 indexed citations breakdown →
14.
Brender, Jean D., Katherine E. Kelley, Martha M. Werler, et al.. (2011). Prevalence and patterns of nitrosatable drug use among U.S. women during early pregnancy. Birth Defects Research Part A Clinical and Molecular Teratology. 91(4). 258–264. 18 indexed citations
15.
Kelley, Katherine E., et al.. (2011). Identification of Phthalates in Medications and Dietary Supplement Formulations in the United States and Canada. Environmental Health Perspectives. 120(3). 379–384. 143 indexed citations
16.
Louik, Carol, Paula Gardiner, Katherine E. Kelley, & Allen A. Mitchell. (2010). Use of herbal treatments in pregnancy. American Journal of Obstetrics and Gynecology. 202(5). 439.e1–439.e10. 58 indexed citations
17.
Hernández–Dı́az, Sonia, Allen A. Mitchell, Katherine E. Kelley, Antonia M. Calafat, & Russ Hauser. (2008). Medications as a Potential Source of Exposure to Phthalates in the U.S. Population. Environmental Health Perspectives. 117(2). 185–189. 187 indexed citations
18.
Kelly, Judith P., David W. Kaufman, Katherine E. Kelley, Lynn Rosenberg, & Allen A. Mitchell. (2006). Use of Herbal/Natural Supplements According to Racial/Ethnic Group. The Journal of Alternative and Complementary Medicine. 12(6). 555–561. 25 indexed citations
19.
Kelly, Judith P., et al.. (2005). Use of postmenopausal hormone therapy since the Women's Health Initiative findings. Pharmacoepidemiology and Drug Safety. 14(12). 837–842. 44 indexed citations
20.
Kelly, Judith P., David W. Kaufman, & Katherine E. Kelley. (2005). Recent Trends in Use of Herbal and Other Natural Products. ACC Current Journal Review. 14(6). 15–15. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026